HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
(2,3-Dihydro-1,4-benzodioxin-6-yl)boronic acid → 3-(4-Cyclopropylpiperazin-1-yl)-6-(2,3-dihydro-1,4-benzodioxin-6-yl)pyridazine, dihydrochloride
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|---|---|---|
| Edukt | (2,3-Dihydro-1,4-benzodioxin-6-yl)boronic acid | HCID 2776178 | — |
| Edukt | 3-Chloro-6-(4-cyclopropylpiperazin-1-yl)pyridazine | HCID 61444150 | — |
| Produkt | 3-(4-Cyclopropylpiperazin-1-yl)-6-(2,3-dihydro-1,4-benzodioxin-6-yl)pyridazine, dihydrochloride | HCID 131730782 | — |
Reaktionsschritte
The title compound was prepared by a similar procedure to that described in Example 68, starting from 3-chloro-6-(4-cyclopropyl-piperazin-1-yl)-pyridazine and 1,4-benzodioxane-6-boronic acid. 1H NMR (400 MHz, DMSO-d6) δ 8.38 (d, 1H), 7.95 (d, 1H), 7.63 (m, 1H), 7.58 (m, 1H), 7.05 (d, 1H), 4.57 (broad m, 2H), 4.32 (m, 4H), 3.63 (broad m, 4H), 3.39 (broad m, 2H), 2.88 (broad m, 1H), 1.23 (m, 2H), 0.82 (m, 2H).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patentnummer | US08846677B2 |
| Quelldatensatz | uspto-grants-2014_09 |
| ORD ID | ord-e8a25d83d6734cd6bb157d13a96e3023 |
| Quellennotiz | uspto-grants-2014_09 |